Ameriprise Financial Inc. Has $44.75 Million Stock Position in Humana Inc. (NYSE:HUM)

Ameriprise Financial Inc. lowered its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 79.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 176,324 shares of the insurance provider's stock after selling 663,020 shares during the quarter. Ameriprise Financial Inc. owned about 0.15% of Humana worth $44,754,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. raised its position in shares of Humana by 15.8% during the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock valued at $3,254,899,000 after buying an additional 1,751,857 shares during the last quarter. Dodge & Cox increased its stake in Humana by 106.7% during the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after acquiring an additional 5,264,045 shares during the period. Pzena Investment Management LLC raised its holdings in Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after acquiring an additional 1,103,132 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Humana by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock worth $729,658,000 after acquiring an additional 63,562 shares during the period. Finally, Invesco Ltd. grew its holdings in shares of Humana by 29.8% during the 4th quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock worth $608,348,000 after purchasing an additional 550,692 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Analysts Set New Price Targets

HUM has been the subject of a number of recent research reports. Barclays upped their target price on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a research note on Friday, April 11th. Morgan Stanley dropped their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research note on Wednesday, February 12th. Mizuho lifted their target price on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Cantor Fitzgerald reissued a "neutral" rating and issued a $290.00 target price on shares of Humana in a research note on Thursday, May 1st. Finally, Truist Financial cut their price target on shares of Humana from $325.00 to $305.00 and set a "hold" rating for the company in a research note on Monday. Seventeen analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $286.81.

Humana Trading Down 9.4%

HUM traded down $23.73 during mid-day trading on Tuesday, reaching $229.13. The stock had a trading volume of 3,840,954 shares, compared to its average volume of 1,752,217. The firm's fifty day simple moving average is $265.02 and its two-hundred day simple moving average is $270.41. The stock has a market capitalization of $27.65 billion, a P/E ratio of 23.03, a P/E/G ratio of 2.05 and a beta of 0.49. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.07 by $1.51. The business had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. The firm's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $7.23 earnings per share. On average, equities analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.54%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.